Patent & IP news archive

OSI Pharmaceuticals LLC et. al.
v. Roxane Laboratories Inc.

Complaint for False Marking
Civil Action No. 1:12-cv-01669-UNA; no judge yet assigned.
Filed on Dec. 7, 2012 in the U.S. District Court for the District of Delaware;

Plaintiffs

v.
OSI Pharmaceuticals
Morris, Nichols, Arsht & Tunnell LLP; Wilmington, DE
Jack B. Blumenfeld
Maryellen Noreika

Patents in case

  • 5,747,498: “Alkynyl and azido-substituted 4-anilinoquinazolines” by Schnur et. al. and assigned to Pfizer Inc.. Prosecuted by Richardson; Peter C. Ginsburg; Paul H. Zielinski; Bryan C.. Includes 32 claims (2 indep.). Was application 08/653,786. Filed 5/28/1996 & Granted 5/5/1998.
  • 6,900,221: “Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof” by Norris et. al. and assigned to OSI Pharmaceuticals, Inc.. Prosecuted by White; John P. Cooper & Dunham LLP. Includes 79 claims (11 indep.). Was application 09/711,272. Filed 11/9/2000 & Granted 5/31/2005.
  • 7,087,613: “Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride” by Norris et. al. and assigned to OSI Pharmaceuticals, Inc.. Prosecuted by Lee; Shu M. Nguyen; Kim T.. Includes 14 claims (1 indep.). Was application 10/992,266. Filed 11/18/2004 & Granted 8/8/2006.

Attorney? Our daily litigation alerts are free, awesome, and include complaint PDFs.

Case documents (PDF)

Fig. 1 from 7,087,613

7,087,613 figure 1

Litigant weblinks

Some content © 2007–2014 RPX Corporation.
Terms of service
Privacy policy
For DMCA requests contact help@priorsmart.com.